MSAM
JNCE
Moloney Securities Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-243,950
| Closed | -$451K | – | 461 |
|
|
2023
Q1 | $451K | Sell |
243,950
-238,500
| -49% | -$441K | 0.08% | 255 |
|
|
2022
Q4 | $536K | Buy |
482,450
+355,119
| +279% | +$394K | 0.12% | 208 |
|
|
2022
Q3 | $298K | Sell |
127,331
-52,200
| -29% | -$122K | 0.07% | 271 |
|
|
2022
Q2 | $544K | Sell |
179,531
-73,300
| -29% | -$222K | 0.13% | 201 |
|
|
2022
Q1 | $1.72M | Sell |
252,831
-63,344
| -20% | -$430K | 0.33% | 82 |
|
|
2021
Q4 | $2.64M | Buy |
316,175
+33,925
| +12% | +$283K | 0.45% | 51 |
|
|
2021
Q3 | $2.1M | Buy |
282,250
+265,650
| +1,600% | +$1.97M | 0.38% | 77 |
|
|
2021
Q2 | $113K | Sell |
16,600
-3,000
| -15% | -$20.4K | 0.02% | 410 |
|
|
2021
Q1 | $201K | Buy |
+19,600
| New | +$201K | 0.04% | 382 |
|